+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 182 Pages
  • Global
From
From
Myasthenia Gravis Treatment - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 89 Pages
  • Global
From
From
From
From
From
From
From
Kidney Transplant Rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Kidney Transplant Rejection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Acute Graft-Versus-Host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Graft-Versus-Host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • June 2024
  • 80 Pages
  • Global
From
Loading Indicator